DUNN GORDON (Chief Financial Officer) purchased 28.86K shares of QUOIN PHARMACEUTICALS, LTD. on the open market
Open‑market purchase worth $23.2K. The strongest form of insider conviction signal.
P · 5 purchases
Filed: 9/11/2024ACC: 0001104659-24-098940
Officer· Chief Financial Officer
Since Jan 2023
+28.86K
Net shares
Net buyer
$23.2K
Total acquired
5
Open market trades
5B · 0S
5
Total transactions
28.86K acquired
Non-Derivative Transactions5
Ordinary Shares
Direct
Shares
+856.00
Price / share
$0.80
Trade value
$684.80
% of position
New position
9/9/2024
0.00→856.00
Ordinary Shares
Direct
Shares
+4K
Price / share
$0.78
Trade value
$3.12K
% of position
467.3%
9/9/2024
856.00→4.86K
Ordinary Shares
Direct
Shares
+4K
Price / share
$0.80
Trade value
$3.20K
% of position
82.4%
9/9/2024
4.86K→8.86K
Ordinary Shares
Direct
Shares
+10K
Price / share
$0.91
Trade value
$9.10K
% of position
112.9%
9/10/2024
8.86K→18.86K
Ordinary Shares
Direct
Shares
+10K
Price / share
$0.71
Trade value
$7.10K
% of position
53.0%
9/10/2024
18.86K→28.86K
Total
Net shares
+28.86K
Net value
$23.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 9/9/2024 | P · Purchase | +856.00 | $0.80 | $684.80 | New position | 0.00 | 856.00 |
| Ordinary Shares Direct | 9/9/2024 | P · Purchase | +4K | $0.78 | $3.12K | 467.3% | 856.00 | 4.86K |
| Ordinary Shares Direct | 9/9/2024 | P · Purchase | +4K | $0.80 | $3.20K | 82.4% | 4.86K | 8.86K |
| Ordinary Shares Direct | 9/10/2024 | P · Purchase | +10K | $0.91 | $9.10K | 112.9% | 8.86K | 18.86K |
| Ordinary Shares Direct | 9/10/2024 | P · Purchase | +10K | $0.71 | $7.10K | 53.0% | 18.86K | 28.86K |
| Total | +28.86K | $23.20K | ||||||
Derivative Transactions0
No derivative transactions reported